Ani Pharmaceuticals Inc (ANIP)

CapEx to Revenue

4.26%

Quarterly · Period ending:

ANIP logo

ANIP CapEx to Revenue

Latest reported4.26%
ANIP Quarterly CapEx/Revenue (0.00% → 4.26%)
High-resolution chart · PNG

ANIP capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.2564%
4.7688%
9.6576%
2.7053%
3.2687%
10.0679%
1.3013%
3.2441%
3.223%
3.3333%
3.63%
3.4537%
5.8569%
2.2035%
3.3343%
11.7083%
1.7886%
3.3779%
0.604%
1.1198%
45.1414%
1.3518%
3.7012%
10.9647%
5.8758%
115.6146%
3.5504%
3.7634%
7.2815%
38.3554%
1.7629%
2.706%
13.2331%
4.9007%
105.9827%
5.1491%
5.147%
144.9547%
3.6356%
2.8267%
194.757%
416.2053%
6.127%
134.0276%
1.0146%
24.5332%
1.6067%
129.5681%
3.8062%
115.9281%
0.2809%
0.4304%
2.0757%
74.4622%
4.1905%
421.6555%
8.3398%
47.5737%
64.9821%
56.1778%
397.1334%
388.1211%
24.1254%
10.0232%
0%
0.3437%
1.1569%
7.0625%
0%
223.1163%
11.0329%
150.9986%
441.0337%
32.0745%
6.509%
1.8405%
0%
0%
0%
25.1903%
1.9321%
0.6141%
22.1716%
2.5406%
34.764%
97.1231%
56.7971%
91.5072%
640.9164%
414.4478%
-7.6506%
0%
0%
0%
0.2254%
0.9355%
0%
0%
-0.5804%
3.0761%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.